Ethic Inc’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $28.6M | Sell |
268,319
-529
| -0.2% | -$56.4K | 0.51% | 21 |
|
2025
Q1 | $27.2M | Buy |
268,848
+26,919
| +11% | +$2.73M | 0.55% | 21 |
|
2024
Q4 | $21.6M | Buy |
241,929
+46,946
| +24% | +$4.19M | 0.44% | 30 |
|
2024
Q3 | $13.4M | Sell |
194,983
-21,479
| -10% | -$1.47M | 0.34% | 52 |
|
2024
Q2 | $16.7M | Buy |
216,462
+21,479
| +11% | +$1.65M | 0.39% | 39 |
|
2024
Q1 | $13.4M | Buy |
194,983
+19,001
| +11% | +$1.3M | 0.34% | 52 |
|
2023
Q4 | $10.2M | Buy |
175,982
+10,646
| +6% | +$615K | 0.3% | 62 |
|
2023
Q3 | $8.73M | Buy |
165,336
+12,470
| +8% | +$658K | 0.31% | 63 |
|
2023
Q2 | $8.27M | Buy |
152,866
+6,241
| +4% | +$338K | 0.31% | 64 |
|
2023
Q1 | $7.34M | Buy |
146,625
+17,655
| +14% | +$883K | 0.3% | 74 |
|
2022
Q4 | $5.97M | Buy |
128,970
+13,082
| +11% | +$605K | 0.32% | 69 |
|
2022
Q3 | $4.49M | Buy |
115,888
+18,959
| +20% | +$734K | 0.3% | 76 |
|
2022
Q2 | $3.61M | Buy |
96,929
+18,281
| +23% | +$681K | 0.25% | 99 |
|
2022
Q1 | $3.48M | Buy |
78,648
+11,979
| +18% | +$531K | 0.24% | 100 |
|
2021
Q4 | $2.83M | Buy |
66,669
+6,895
| +12% | +$293K | 0.22% | 114 |
|
2021
Q3 | $2.59M | Buy |
59,774
+7,797
| +15% | +$338K | 0.27% | 89 |
|
2021
Q2 | $2.22M | Buy |
51,977
+18,058
| +53% | +$772K | 0.27% | 83 |
|
2021
Q1 | $1.31M | Buy |
33,919
+14,693
| +76% | +$568K | 0.23% | 105 |
|
2020
Q4 | $691K | Sell |
19,226
-1,979
| -9% | -$71.1K | 0.18% | 139 |
|
2020
Q3 | $810K | Buy |
21,205
+14,449
| +214% | +$552K | 0.31% | 84 |
|
2020
Q2 | $237K | Buy |
+6,756
| New | +$237K | 0.13% | 207 |
|
2020
Q1 | – | Sell |
-5,445
| Closed | -$246K | – | 214 |
|
2019
Q4 | $246K | Buy |
+5,445
| New | +$246K | 0.18% | 179 |
|